Topical drug delivery market to reach $123bn by 2024

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/Photoboyko)
(Image: Getty/Photoboyko)

Related tags: Drug delivery systems, Drug delivery technologies, global market, R&D

High prevalence of skin disease and diabetes to boost the global revenues of the topical drug delivery market, with uptake in China and India boosting growth.

The global market of drug products administered by topical application is expected to sustain 5.7% year-over-year growth, a research​ conducted by Markets and Markets shows.

The topical drug delivery market includes medicines indicated for dermal, ophthalmic, rectal, vaginal and nasal administration.

According to the research report, the market is currently worth $93.2bn (€83.94bn) and is projected to reach $123.2bn by 2024, mainly due to the high prevalence of skin diseases and diabetes, as well as the rising incidences of eye diseases and burn injuries.

The largest share of the market is likely to be accounted for by products of semi-solid formulations, such as creams, gels, ointments, pastes, and lotions, because they offer easy application and enable the intake of a wide variety of molecules, M&M states.

The dermal drug delivery segment dominated the market in 2018 and is expected to continue to do so due to the high prevalence of skin cancer. Approximately 3 million people are diagnosed with this type of cancer annually across the globe, according to the WHO.

The M&M research also found that the home care settings segment accounts for the largest share of the market, surpassing the hospital settings, due to the products’ ease of use and affordability.

Market challenges

Despite its projected growth, the market of topical drug delivery faces challenges, which include the technical barriers related to skin irritation and permeability, in addition to drug failures and product recalls, according to the report.

In July, US-based Altaire Pharmaceuticals proceeded with a voluntary recall​ of sterile ophthalmic treatments, after concerns were raised about quality assurance at its manufacturing facility.

In addition, a further factor that may restrict the market’s growth would be the preference for alternative drug delivery methods, such as oral, injectables, and pulmonary.

Topical drug delivery market

Emerging R&D in Japan boosts the market

The region anticipated to produce the highest revenues within the market during the forecast period will be North America, although emerging markets such as China and India are expected to offer potential growth opportunities, the report suggests.

However, Japan is expected to witness the highest annual growth rate and this can be attributed to the rising geriatric population, increasing the uptake of generic drugs.

Additionally, the research shows the growing number of product approvals and launches in Japan, and the increasing focus of local players on the R&D of topical formulations boosting the revenues of the market in the country.

Related news

Show more

Related products

show more

From Candidate to Clinic- European Capabilities

From Candidate to Clinic- European Capabilities

Catalent Pharma Solutions | 22-Oct-2018 | Technical / White Paper

Catalent’s Nottingham, UK facility focuses on early stage development of small molecule drug candidates from the bench to clinic. This facility offers...

Fill Release at the Right Time in the Right Place

Fill Release at the Right Time in the Right Place

Gelita AG | 19-Sep-2018 | Technical / White Paper

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Related suppliers

Follow us

Products

View more

Webinars